A subgroup analysis presented at ESMO evaluated the clinical performance of...
A retrospective analysis of the UNITE study evaluated the efficacy of EV plus...
The CLEAR trial was a large phase III randomised study evaluating first-line...
Dr Anouk Goudsmit presented an e-poster at the ESMO 2025 Congress on the...
Dr Annelies presented a poster on the FALCON Lung Study at the ESMO Annual...
Prof Mark Vincent presented results from a Canadian multicenter study...
Prof Jean-Pascal Machiels discusses the patient reported outcome data for the...
Since IMPOWER-133 and CASPIAN, chemoimmunotherapy has become the standard...
ZORALCS is a four-year prospective, feasibility implementation study evaluating...
In this video, Dr Willem Lybaert talks us through the key take aways of the...